digital therapeutics and cardiovascular disease prevention: innovation and its potential value about whether the market has encouraged and will encourage innovation in the future or how the innovation of DTx will change the structure, conduct, or performance of the market. On equity, research will help but how about the performance of the market or whether changes in the market because of DTx are likely to lead to more or less equity than we see now?